Investment in NGS continues as Roche add new names to their list of acquisitions.
New start-up companies are constantly commercialising new technologies and services. Genomics is ripe for investment right now.
Dean Schorno, former CFO of Adaptive Technologies Corp, joins 23andMe amid plans to relaunch health-focused products.
Editas Medicine raises more funds to develop CRISPR-Cas9 for clinical application.
Startups in infectious diseases, urology and wine to receive the golden handshake from Illumina Accelerator business incubator
Sophia Genetics move into the Spanish market in their mission to reach 100 partnerships by the end of the year.
Genomics England Clinical Interpretation Partnership
Oak HC/FT lead Series B funding for informatics company. Hot on the heels of being nominated as a “Cool Vendor” by Gartner (a technology research and advisory firm), and winning Best of Show at BioIT Word in April, Core Informatics have come out as winners once again. The data management software company closed a $17.5 […]